Spinal muscular atrophy is a relatively stable chronic disease. Patients may gradually experience declines in muscle strength and motor function over time. However, functional progression is difficult to document, and the mechanism remains poorly understood. An 11-year-old girl was diagnosed at 19 months and took a few steps without assistance at 25 months. She was evaluated for 54 months in a prospective multicenter natural history study. Outcome measures were performed serially. From 6 to 7.5 years, motor function improved. From 7.5 to 11 years, motor function declined with increasing growth. Manual muscle testing scores minimally decreased. Motor unit number estimation studies gradually increased over 4.5 years. Compared to the published natural history of spinal muscular atrophy type III, our patient lost motor function over time. However, she walked with assistance 2 years longer than expected. Our report highlights possible precipitating factors that could affect the natural history of spinal muscular atrophy type III.
CrawfordTO. Spinal muscular atrophies. In: JonesRHDe VivoDCDarrasBT, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician’s Approach. Philadelphia, PA: Butterworth Heinemann; 2003:145–166.
2.
DubowitzV. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord. 1995;5(1):3–5.
3.
KaufmannPMcDermottMPDarrasBT. Muscle Study Group; Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. 2011;68(6):779–786.
4.
ZerresKRudnik-SchonebornS.Natural history in proximal spinal muscular atrophy: clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518–523.
5.
ZerresKRudnik-SchonebornSForrestELusakowskaABorkowskaJHausmanowa-PetrusewiczI. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;146(1):67–72.
6.
DeymeerFSerdarogluPParmanYPodaM. Natural history of SMA IIIB. Neurology. 2008;71:664–649.
7.
KroksmarkAKBeckungETuliniusM. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III. Eur J Paediatr Neurol. 2001;5(5):191–198.
8.
RussmanBSBuncherCRWhiteMSamahaFJIannacconeST. Function changes in spinal muscular atrophy II and III. The DCN/SMA Group. Neurology. 1996;47(4):973–976.
9.
EscolarDMHenricsonEKMayhewJ. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve. 2001;24(6):787–793.
10.
SwobodaKJPriorTWScottCB. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol. 2005;57(5):704–712.
11.
NelsonLOwensHHynanLSIannacconeST. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy. Neuromuscul Disord. 2006;16(6):374–380.
12.
MainMKaironHMercuriEMuntoniF. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol. 2003;7(4):155–159.
13.
O’HagenJ MGlanzmanAMMcDermottMP. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord. 2007;17(9-10):693–697.
14.
FlorenceJMPandyaSKingWM. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne’s muscular dystrophy. Phys Ther. 1992;72(2):115–122; discussion 122-126.
15.
ScottOMHydeSAGoddardCDubowitzV. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982;5(4):291–301.
16.
WerlauffUSteffensenBFBertelsenSFloytrupIKristensenBWergeB. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscul Disord. 2010;20:34–43.
17.
DeymeerFSerdarogluPPodaMGulsen-ParmanYOzcelikTOzdemirC. Segmental distribution of muscle weakness in SMA III: implications for deterioration in muscle strength with time. Neuromuscul Disord. 1997;7:521–528.
18.
MerliniLBertiniEMinettiC. Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve. 2004;29:548–552.
19.
CarterGTAbreschRTFowlerWMJrJohnsonERKilmerDDMcDonaldCM. Profiles of neuromuscular diseases. Spinal muscular atrophy. Am J Phys Med Rehabil. 1995;74(5 suppl):S150–S159.
20.
WangHYYangYHJongYJ. Evaluation of muscle strength in patients with spinal muscular atrophy. Kaohsiung J Med Sci. 2002;18(5):241–247.
21.
KochBMSimensonRL. Upper extremity strength and function in children with spinal muscular atrophy type II. Arch Phys Med Rehabil. 1992;73(3):241–245.
22.
MerliniLMazzoneESSolariAMorandiL. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve. 2002;26(1):64–70.
23.
WangXDockeryDWWypijDFayMEFerrisBGJr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol. 1993;15(2):75–88.
ArmonCBrandstaterME. Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve. 1999;22(11):1571–1575.
26.
GaleaVFehlingsDKirschSMcComasA. Depletion and sizes of motor units in spinal muscular atrophy. Muscle Nerve. 2001;24(9):1168–1172.
27.
HaleySMLudlowLH. Applicability of the hierarchical scales of the Tufts Assessment of Motor Performance for school-aged children and adults with disabilities. Phys Ther. 1992;72(3):191–202; discussion 202-206.
28.
FeldmanABHaleySMCoryellJ. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther. 1990;70(10):602–610.
29.
BergMJahnsenRFroslieKFHussainA. Reliability of the Pediatric Evaluation of Disability Inventory (PEDI). Phys Occup Ther Pediatr. 2004;24(3):61–77.
30.
ParanoEFiumaraAFalsaperlaRPavoneL. A clinical study of childhood spinal muscular atrophy in Sicily: a review of 75 cases. Brain Dev. 1994;16(2):104–107.
31.
SteffensenBFLyagerSWergeBRahbekJMattssonE. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002;44(9):623–632.
32.
BenadySG. Spinal muscular atrophy in childhood: review of 50 cases. Dev Med Child Neurol. 1978;20(6):746–757.
33.
MunsatTLSkerryLKorfB. Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q). Neurology. 1990;40(12):1831–1836.
34.
RussmanBSMelchreitRDrennanJC. Spinal muscular atrophy: the natural course of disease. Muscle Nerve. 1983;6(3):179–181.
RussmanBSIannaconeSTBuncherCR. Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema. J Child Neurol. 1992;7(4):347–353.
37.
IannacconeSTRussmanBSBrowneRHBuncherCRWhiteMSamahaFJ. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. J Child Neurol. 2000;15(2):97–101.
38.
SouchonFSimardLRLebrunSRochetteCLambertJVanasseM. Clinical and genetic study of chronic (types II and III) childhood onset spinal muscular atrophy. Neuromuscul Disord. 1996;6(6):419–424.
39.
SchwentkerEPGibsonDA. The orthopaedic aspects of spinal muscular atrophy. J Bone Joint Surg Am. 1976;58(1):32–38.
40.
MitsumotoHUlugAMPullmanSL. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 2007;68(17):1402–1410.
41.
DubowitzV. Muscle disorders in childhood. Major Probl Clin Pediatr. 1978;16:iii-xiii, 1–282.
42.
KanningKCKaplanAHendersonCE. Motor neuron diversity in development and disease. Annu Rev Neurosci. 2010;33:409–440.
43.
BrombergMBSwobodaKJ. Motor unit number estimation in infants and children with spinal muscular atrophy. Muscle Nerve. 2002;25(3):445–447.
